Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Nasopharyngeal Carcinoma 7Esophageal Squamous Cell Carcinoma 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumor 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Advanced Breast Cancer 2Urinary Bladder Neoplasms 1Turcot syndrome 1Solid Tumor 1Skin Neoplasms 1Sarcoma 1Recurrence 1Papillomavirus Infections 1Pancreatic Cancer Metastatic 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Muscle Invasive Bladder Cancer (MIBC) 1Mouth Neoplasms 1Meningeal Carcinomatosis 1Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1

Interventions

Nivolumab 37pembrolizumab 26cabozantinib 26Specimen Handling 23Magnetic Resonance Spectroscopy 21Ipilimumab 19lenvatinib 13belzutifan 13Axitinib 13CTLA-4 Antigen 10Sunitinib 9Radiosurgery 8Biopsy 8atezolizumab 7fludarabine 4avelumab 4aldesleukin 4Immunoglobulin G 4Disulfides 4zimberelimab 3toripalimab 3tivozanib 3pazopanib 3palbociclib 3durvalumab 3cemiplimab 3Surveys and Questionnaires 3Nephrectomy 3Everolimus 3Cyclophosphamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × toripalimab × 90 days × Clear all
NCT07571551 2026-05-11

TRIPLE-PATH

Jinling Hospital, China

Phase 2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07500831 2026-03-30

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
43 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05738694 2026-03-17

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

Sun Yat-sen University

Phase 3 Recruiting
298 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡